Cargando…

An update on the biologics for the treatment of antiphospholipid syndrome

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by thrombosis and pregnancy morbidity with the persistent presence of antiphospholipid antibodies (aPLs). Although anticoagulation is the primary treatment for APS, it fails in approximately 20-30% of obstetric APS cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Zelin, Duan, Lizhi, Liu, Xiangjun, Cai, Qingmeng, Li, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237350/
https://www.ncbi.nlm.nih.gov/pubmed/37275894
http://dx.doi.org/10.3389/fimmu.2023.1145145

Ejemplares similares